So Sorry L

 

From: Susan Sutherland, Ph.D.
Sent: Tuesday, January 29, 2013 5:12 PM
To: 'Research Administration Discussion List'
Subject: RE: Subrecipient monitoring questions

 

Tami,

Are you an SRA member?

 

Susan E. Sutherland, Ph.D., CHRC

Director, Research Institute

phone: (828) 213-7038

Cell: (828) 775-7211

New Location: 84 Coxe Avenue, Suite 2A

New fax: 828-252-8221

Mailing Address:  509 Biltmore Avenue

Asheville, NC 28801

 

From: Research Administration List [mailto:xxxxxx@lists.healthresearch.org] On Behalf Of Spires, Michael
Sent: Tuesday, January 29, 2013 10:13 AM
To: xxxxxx@lists.healthresearch.org
Subject: Re: [RESADM-L] Subrecipient monitoring questions

 

I don’t know if he’s on this list, but Paul Kingsbury (director of sponsored programs at the University of South Dakota) did a nice presentation at the SRA Midwest/South section meeting in Cincinnati last year: and he included a risk matrix form that they used in his presentation. I’m not sure if it’s the full-featured one they use in-house, but if you’re an SRA member you can access his presentation and download it from there. Or reach out to him (he’s very nice), and I’m sure he’d be willing to share.

 

 

Michael Spires

Proposal Development Specialist

Office of Sponsored Projects

Smithsonian Institution

Mail: MRC 1205, P. O. Box 37012

Washington, DC 20013-7012

Voice: (202) 633-7436

Mobile: (202) 251-4317

Main office: (202) 633-7110

Fax: (202) 633-7119

http://prism.si.edu/osp/FundingSources/ProposalDevelopment/PropDev.html

 

 

 

From: Research Administration List [mailto:xxxxxx@lists.healthresearch.org] On Behalf Of McWhorter,Sharon
Sent: Tuesday, January 29, 2013 09:00
To: xxxxxx@lists.healthresearch.org
Subject: [RESADM-L] Subrecipient monitoring questions

 

Good morning:

 

We recently  participated in a webinar on Subrecipient Monitoring and consequently are looking at ways we can improve our internal processes. We are turning to the group for information/examples.

 

One suggestion made by the presenter was to conduct a risk assessment of subrecipients to insure they have the necessary capabilities, are familiar with grant regulations, and have adequate financial accounting systems/policies. Has anyone developed a form to collect this information and, if so, do you collect it during proposal preparation (with the LOI from the subrecipient) or upon award (with the subaward agreement)? Would you be willing to share it?

 

The circular A-110 requires records be kept for 3 years after the final financial report is filed (with some exceptions). That retention period is included in our standard subaward agreement, however, the false claims act states that you should keep records for 6 years after the final report. Has anyone revised their retention policies from 3 years to 6 or 7 to take into account the false claims act timeline?

 

Thank you for any information you are able and willing to provide!

 

Sharon McWhorter
Associate Director

Office of Research Administration

The University of Akron
330-972-8311
xxxxxx@uakron.edu

 

====================================================================== Instructions on how to use the RESADM-L Mailing List, including subscription information and a web-searchable archive, are available via our web site at http://www.healthresearch.org (click on the "LISTSERV" link in the upper right corner)

A link directly to helpful tips: http://tinyurl.com/resadm-l-help ======================================================================

====================================================================== Instructions on how to use the RESADM-L Mailing List, including subscription information and a web-searchable archive, are available via our web site at http://www.healthresearch.org (click on the "LISTSERV" link in the upper right corner)

A link directly to helpful tips: http://tinyurl.com/resadm-l-help ======================================================================

----------------------------------------- This message and its attachments may contain confidential and/or legally-sensitive information that is intended for the sole use of the addressee(s). Any unauthorized review, use, disclosure, or distribution of the information contained in this message and its attachments is prohibited. If you have received this message or any of its attachments in error, please destroy all originals and copies of the same and notify the sender immediately.

====================================================================== Instructions on how to use the RESADM-L Mailing List, including subscription information and a web-searchable archive, are available via our web site at http://www.healthresearch.org (click on the "LISTSERV" link in the upper right corner)

A link directly to helpful tips: http://tinyurl.com/resadm-l-help ======================================================================